CD8A and cancer: The clock furthermore enforces diurnal changes in immune checkpoint expression on CD8+ T cells and myeloid-derived suppressor cells, thus timely affecting the efficacy of immune checkpoint inhibition and CAR T cell therapy in murine cancer model systems.87